BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12928529)

  • 1. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
    Aridogan BC; Yildirim M; Baysal V; Inaloz HS; Baz K; Kaya S
    J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis.
    Ozyurt K; Celik A; Sayarlıoglu M; Colgecen E; Incı R; Karakas T; Kelles M; Cetin GY
    J Oral Pathol Med; 2014 Oct; 43(9):691-5. PubMed ID: 24801453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
    Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
    Front Immunol; 2021; 12():724900. PubMed ID: 35003055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
    Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
    Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
    Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
    J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H; Xia LP; Lu J
    Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of serum nitric oxide levels in Behçet's disease and recurrent aphthous stomatitis.
    Yildirim M; Baysal V; Inaloz HS; Doguc D
    J Dermatol; 2004 Dec; 31(12):983-8. PubMed ID: 15801262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis].
    Guenane H; Hartani D; Chachoua L; Lahlou-Boukoffa OS; Mazari F; Touil-Boukoffa C
    J Fr Ophtalmol; 2006 Feb; 29(2):146-52. PubMed ID: 16523155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
    Frassanito MA; Dammacco R; Cafforio P; Dammacco F
    Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
    Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E; Cosan F; Cefle A; Deniz G
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
    Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
    Pekiner FN; Aytugar E; Demirel GY; Borahan MO
    J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B; Xie C; Lin X; Su SB
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.
    Aktas Cetin E; Cosan F; Kucuksezer UC; Bilgic S; Cagatay Y; Gul A; Deniz G
    Rheumatol Int; 2013 Mar; 33(3):733-41. PubMed ID: 22576660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.
    Dalghous AM; Freysdottir J; Fortune F
    Scand J Rheumatol; 2006; 35(6):472-5. PubMed ID: 17343257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
    Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
    Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.